These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 531731)

  • 1. Erythromycin resistance in mouse L cells.
    Molloy PL; Eisenstadt JM
    Somatic Cell Genet; 1979 Sep; 5(5):585-95. PubMed ID: 531731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbomycin resistance in mouse L cells.
    Bunn CL; Eisenstadt JM
    Somatic Cell Genet; 1977 Nov; 3(6):611-27. PubMed ID: 601682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic inheritance of erythromycin resistance in human cells.
    Doersen CJ; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4549-53. PubMed ID: 291986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial antibiotic resistance in yeast: ribosomal mutants resistant to chloramphenicol, erythromycin and spiramycin.
    Grivell LA; Netter P; Borst P; Slonimski PP
    Biochim Biophys Acta; 1973 Jun; 312(2):358-67. PubMed ID: 4579232
    [No Abstract]   [Full Text] [Related]  

  • 5. Sub-inhibitory and post-antibiotic effects of spiramycin and erythromycin on Staphylococcus aureus.
    Webster C; Ghazanfar K; Slack R
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():33-9. PubMed ID: 3182445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythromycin and spiramycin resistance mutations of yeast mitochondria: nature of the rib2 locus in the large ribosomal RNA gene.
    Sor F; Fukuhara H
    Nucleic Acids Res; 1984 Nov; 12(22):8313-8. PubMed ID: 6095195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial genetics. VII. Allelism and mapping studies of ribosomal mutants resistant to chloramphenicol, erythromycin and spiramycin in S. cerevisiae.
    Netter P; Petrochilo E; Slonimski PP; Bolotin-Fukuhara M; Coen D; Deutsch J; Dujon B
    Genetics; 1974 Dec; 78(4):1063-100. PubMed ID: 4281750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of evidence for mutation to erythromycin resistance in clinical strains of Staphylococcus aureus.
    Lacey RW
    J Clin Pathol; 1977 Jul; 30(7):602-5. PubMed ID: 886013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
    Dibb WL; Ragnhildstveit E
    NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XXIV. Effect of mikamycin, carbomycin, spiramycin, erythromycin, and paromomycin on growth and respiration of HeLa cells.
    Dixon H; Kellerman GM; Linnane AW
    Arch Biochem Biophys; 1972 Oct; 152(2):869-75. PubMed ID: 4635794
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogenesis of mitochondria. 18. A new class of cytoplasmically determined antibiotic resistant mutants in Saccharomyces cerevisiae.
    Bunn CL; Mitchell CH; Lukins HB; Linnane AW
    Proc Natl Acad Sci U S A; 1970 Nov; 67(3):1233-40. PubMed ID: 5274452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of erythromycin and carbomycin in combined antibiotic action in vitro.
    COLEMAN VR; GUNNISON JB; JAWETZ E
    Proc Soc Exp Biol Med; 1953; 83(4):668-70. PubMed ID: 13120847
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
    Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
    Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of clindamycin, erythromycin and spiramycin against Staphylococcus aureus in the rat croton oil pouch model.
    Davey PG; Jacobus NV; Tally FP
    J Antimicrob Chemother; 1987 Nov; 20(5):705-12. PubMed ID: 3429372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symposium No. 8: Non-chromosomal inheritance. Genetic control of mitochondria in paramecium.
    Beisson J; Sainsard A; Adoutte A
    Genetics; 1974 Sep; 78(1):403-13. PubMed ID: 4442713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
    Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
    Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus].
    Rolin O; Bouanchaud DH
    Pathol Biol (Paris); 1989 May; 37(5):375-7. PubMed ID: 2780094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cross resistance to erythromycin and carbomycin in Micrococcus pyogenes var. aureus.
    HSIE JY; KOTZ R; NUSSER W
    Antibiot Annu; 1955-1956; 3():773-7. PubMed ID: 13355361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.